FULL TEST BANK
PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 3RD EDITION
BY LINDA LANE LILLEY CHAPTER 1-58
,Table of Contents
Chapter 01: Nursing Practice In Canada And Drug Therapy ....................................................................... 4
Chapter 02: Pharmacological Principles ...................................................................................................... 9
Chapter 03: Legal And Ethical Considerations ........................................................................................... 14
Chapter 04: Patient Focused Considerations ............................................................................................ 19
Chapter 05: Gene Therapy And Pharmacogenomics ................................................................................ 27
Chapter 06: Medication Errors: Preventing And Responding ................................................................... 29
Chapter 07: Patient Education And Drug Therapy .................................................................................... 32
Chapter 08: Over-The-Counter Drugs And Natural Health Products ........................................................ 36
Chapter 09: Vitamins And Minerals ........................................................................................................... 40
Chapter 10: Principles Of Drug Administration ......................................................................................... 44
Chapter 11: Analgesic Drugs ...................................................................................................................... 53
Chapter 12: General And Local Anaesthetics ............................................................................................ 59
Chapter 13: Central Nervous System Depressants And Muscle Relaxants .............................................. 64
Chapter 14: Central Nervous System Stimulants And Related Drugs ...................................................... 70
Chapter 15: Antiepileptic Drugs ................................................................................................................. 75
Chapter 16: Antiparkinsonian Drugs ......................................................................................................... 80
Chapter 17: Psychotherapeutic Drugs ....................................................................................................... 84
Chapter 18: Substance Misuse ................................................................................................................... 90
Chapter 19: Adrenergic Drugs .................................................................................................................... 96
Chapter 20: Adrenergic-Blocking Drugs................................................................................................... 101
Chapter 21: Cholinergic Drugs ................................................................................................................. 106
Chapter 22: Cholinergic-Blocking Drugs .................................................................................................. 111
Chapter 23: Antihypertensive Drugs ....................................................................................................... 116
Chapter 24: Antianginal Drugs ................................................................................................................. 121
Chapter 25: Heart Failure Drugs .............................................................................................................. 126
Chapter 26: Antidysrhythmic Drugs ........................................................................................................ 132
Chapter 28: Antilipemic Drugs ................................................................................................................. 142
Chapter 29: Diuretic Drugs ....................................................................................................................... 148
Chapter 30: Fluids And Electrolytes ......................................................................................................... 154
Chapter 31: Pituitary Drugs ...................................................................................................................... 159
Chapter 32: Thyroid And Antithyroid Drugs ............................................................................................ 163
Chapter 33: Antidiabetic Drugs ................................................................................................................ 168
,Chapter 34: Adrenal Drugs ....................................................................................................................... 174
Chapter 35: Women’s Health Drugs ........................................................................................................ 178
Chapter 36: Men’s Health Drugs .............................................................................................................. 185
Chapter 37: Antihistamines, Decongestants, Antitussives, And Expectorants ...................................... 190
Chapter 38: Respiratory Drugs ................................................................................................................. 195
Chapter 39: Acid-Controlling Drugs ......................................................................................................... 200
Chapter 40: Antidiarrheal Drugs And Laxatives ...................................................................................... 206
Chapter 41: Antiemetic And Anti-Nausea Drugs ..................................................................................... 211
Chapter 42: Nutritional Supplements ...................................................................................................... 215
Chapter 43: Antibiotics, Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, And
Tetracyclines ............................................................................................................................................. 219
Chapter 44: Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, And Other Drugs ....................... 224
Chapter 45: Antiviral Drugs ...................................................................................................................... 228
Chapter 46: Antitubercular Drugs ............................................................................................................ 233
Chapter 47: Antifungal Drugs................................................................................................................... 238
Chapter 48: Antimalarial, Antiprotozoal, And Anthelmintic Drugs ........................................................ 243
Chapter 49: Anti-Inflammatory And Antigout Drugs .............................................................................. 247
Chapter 50: Immunosuppressant Drugs .................................................................................................. 252
Chapter 51: Immunizing Drugs And Pandemic Preparedness ................................................................ 256
Chapter 52: Antineoplastic Drugs Part 1: Cancer Overview And Cell Cycle–Specific Drugs .................. 261
Chapter 53: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific And Miscellaneous Drugs ................ 266
Chapter 54: Biological Response–Modifying Drugs ................................................................................ 268
Chapter 55: Anemia Drugs ....................................................................................................................... 272
Chapter 56: Dermatological Drugs........................................................................................................... 277
Chapter 57: Ophthalmic Drugs................................................................................................................. 282
Chapter 58: Otic Drugs ............................................................................................................................. 286
,Chapter 01: Nursing Practice In Canada And Drug Therapy
Lilley: Pharmacology For Canadian Health Care Practice, 3rd Canadian Edition
MULTIPLE CHOICE
1.Which Is A Judgement About A Particular Patient‘S Potential Need Or Problem?
A. A Goal
B. An Assessment
C. Subjective Data
D. A Nursing Diagnosis
CORRECT ANSWER: D
Nursing Diagnosis Is The Phase Of The Nursing Process During Which A Clinical Judgement Is Made
About How A Patient Responds To Heath Conditions And Life Processes Or Vulnerability For That
Response.
DIF:Cognitive Level: Knowledge
REF: P. 11
2. The Patient Is To Receive Oral Furosemide (Lasix) Every Day; However, Because The Patient Is Unable
To Swallow, He Cannot Take Medication Orally, As Ordered. The NURSE Needs To Contact The Physician.
What Type Of Problem Is This?
A. A ―Right Time‖ Problem
B. A ―Right Dose‖ Problem
C. A ―Right Route‖ Problem
D. A ―Right Medication‖ Problem
CORRECT ANSWER: C
This Is A ―Right Route‖ Problem: The NURSE Cannot Assume The Route And Must Clarify The Route
With The Prescriber. This Is Not A ―Right Time‖ Problem Because The Ordered Frequency Has Not
Changed. This Is Not A ―Right Dose‖ Problem Because The Dose Is Not Related To An Inability To
Swallow. This Is Not A ―Right Medication‖ Problem Because The Medication Ordered Will Not
Change, Just The Route.
DIF: Cognitive Level: Application
,REF: P. 14
3. The NURSE Has Been Monitoring The Patient‘S Progress On His New Drug Regimen Since The First
Dose And Has Been Documenting Signs Of Possible Adverse Effects. What Nursing Process Phase Is The
NURSE Practising?
A. Planning
B. Evaluation
C. Implementation
D. Nursing Diagnosis
CORRECT ANSWER: B
Monitoring The Patient‘S Progress Is Part Of The Evaluation Phase. Planning, Implementation, And
Nursing Diagnosis Are Not Illustrated By This Example.
DIF: Cognitive Level: Application
REF: P. 19
4. The NURSE Is Caring For A Patient Who Has Been Newly Diagnosed With Type 1 Diabetes Mellitus.
Which Statement Best Illustrates An Outcome Criterion For This Patient?
A. The Patient Will Follow Instructions.
B. The Patient Will Not Experience Complications.
C. The Patient Adheres To The New Insulin Treatment Regimen.
D. The Patient Demonstrates Safe Insulin Self-Administration Technique.
CORRECT ANSWER: D
Having The Patient Demonstrate Safe Insulin Self-Administration Technique Is A Specific And
Measurable Outcome Criterion. Following Instructions And Avoiding Complications Are Not Specific
Criteria. Adherence To The New Insulin Treatment Regimen Is Not Objective And Would Be Difficult To
Measure.
DIF: Cognitive Level: Application
REF: P. 13
5. Which Activity Best Reflects The Implementation Phase Of The Nursing Process For The Patient Who Is
Newly Diagnosed With Type 1 Diabetes Mellitus?
A. Providing Education Regarding Self-Injection Technique
,B. Setting Goals And Outcome Criteria With The Patient‘S Input
C. Recording A History Of Over-The-Counter Medications Used At Home
D. Formulating Nursing Diagnoses Regarding Knowledge Deficits Related To The New Treatment
Regimen
CORRECT ANSWER: A
Education Is An Intervention That Occurs During The Implementation Phase. Setting Goals And
Outcome Criteria Reflects The Planning Phase. Recording A Drug History Reflects The Assessment
Phase. Formulating Nursing Diagnoses Regarding A Knowledge Deficit Reflects Analysis Of Data
As Part Of The Planning Phase.
DIF: Cognitive Level: Analysis
REF: P. 8 | P. 13
6. The NURSE Is Working During A Very Busy Night Shift, And The Health Care Provider Has Just Given
The NURSE A Medication Order Over The Telephone, But The NURSE Does Not Recall The Route. What Is
The Best Way For The NURSE To Avoid Medication Errors?
A. Recopy The Order Neatly On The Order Sheet, With The Most Common Route Indicated
B. Consult With The Pharmacist For Clarification About The Most Common Route
C. Call The Health Care Provider To Clarify The Route Of Administration
D. Withhold The Drug Until The Health Care Provider Visits The Patient
CORRECT ANSWER: C
If A Medication Order Does Not Include The Route, The NURSE Must Ask The Health Care Provider To
Clarify It. Never Assume The Route Of Administration.
DIF: Cognitive Level: Application | Cognitive Level: Analysis
REF: P. 17
7. Which Constitutes The Traditional Five Rights Of Medication Administration?
A. Right Drug, Right Route, Right Dose, Right Time, And Right Patient
B. Right Drug, The Right Effect, The Right Route, The Right Time, And The Right Patient
C. Right Patient, Right Strength, Right Diagnosis, Right Drug, And Right Route
D. Right Patient, Right Diagnosis, Right Drug, Right Route, And Right Time
CORRECT ANSWER: A
,The Traditional Five Rights Of Medication Administration Were Considered To Be Right Drug, Right
Route, Right Dose, Right Time, And Right Patient. Right Effect, Right Strength, And Right Diagnosis Are
Not Part Of The Traditional Five Rights.
DIF: Cognitive Level: Comprehension
REF: P. 13
8. What Correctly Describes The Nursing Process?
A. Diagnosing, Planning, Assessing, Implementing, And Finally Evaluating
B. Assessing, Then Diagnosing, Implementing, And Ending With Evaluating
C. A Linear Direction That Begins With Assessing And Continues Through Diagnosing, Planning, And
Finally Implementing
D. An Ongoing Process That Begins With Assessing And Continues With Diagnosing, Planning,
Implementing, And Evaluating
CORRECT ANSWER: D
The Nursing Process Is An Ongoing, Flexible, Adaptable, And Adjustable Five-Step Process That Begins
With Assessing And Continues Through Diagnosing, Planning, Implementing, And Finally Evaluating,
Which May Then Lead Back To Any Of The Other Phases.
DIF: Cognitive Level: Application
REF: P. 8
9. When The NURSE Is Considering The Timing Of A Drug Dose, Which Is Most Important To Assess?
A. The Patient‘S Identification
B. The Patient‘S Weight
C. The Patient‘S Last Meal
D. Any Drug Or Food Allergies
CORRECT ANSWER: C
The Pharmacokinetic And Pharmacodynamic Properties Of The Drug Need To Be Assessed With
Regard To Any Drug–Food Interactions Or Compatibility Issues. The Patient‘S Identification, Weight,
And Drug Or Food Allergies Are Not Affected By The Drug‘S Timing.
,DIF: Cognitive Level: Application
REF: P. 17
10. The NURSE Is Writing Nursing Diagnoses For A Plan Of Care. Which Reflects The Correct Format For
Her Nursing Diagnosis?
A. Anxiety
B. Anxiety Related To New Drug Therapy
C. Anxiety Related To Anxious Feelings About Drug Therapy, As Evidenced By Statements Such As
―I‘M Upset About Having To Give Myself Shots‖
D. Anxiety Related To New Drug Therapy, As Evidenced By Statements Such As ―I‘M Upset About
Having To Give Myself Shots‖
CORRECT ANSWER: D
Formulation Of Nursing Diagnoses Is Usually A Three-Step Process. The Only Complete Answer Is
―Anxiety Related To New Drug Therapy, As Evidenced By Statements Such As ‗I‘M Upset About
Having To Give Myself Shots.‘‖ The Answer ―Anxiety‖ Is Missing The ―Related To‖ And ―As
Evidenced By‖ Portions. The Answer ―Anxiety Related To New Drug Therapy‖ Is Missing The ―As
Evidenced By‖ Portion Of Defining Characteristics. The ―Related To‖ Section In ―Anxiety Related To
Anxious Feelings About Drug Therapy, As Evidenced By Statements Such As ‗I‘M Upset About Having
To Give Myself Shots‘‖ Is Simply A Restatement Of The Problem ―Anxiety,‖ Not A Separate Factor
Related To The Response.
DIF: Cognitive Level: Analysis
REF: P. 9
OTHER
1. Place The Phases Of The Nursing Process In The Correct Order, Starting With The First Phase.
A. Planning
B. Evaluation
C. Assessment
D. Implementation
E. Diagnosing
CORRECT ANSWER>>
,C, E, A, D, B
DIF: Cognitive Level: Analysis
REF: P. 9
Chapter 02: Pharmacological Principles
Lilley: Pharmacology For Canadian Health Care Practice, 3rd Canadian Edition
MULTIPLE CHOICE
1. A Patient Is Receiving Two Different Drugs, Which, At Their Current Dose Forms And Dosages, Are
Both Absorbed Into The Circulation In Identical Amounts. Which Term Best Denotes That The Drugs
Have The Same Absorption Rates?
A. Equivalent
B. Synergistic
C. Compatible
D. Bioequivalent
CORRECT ANSWER: D
Two Drugs Absorbed Into The Circulation At The Same Amount (In Specific Dosage Forms) Have The
Same Bioavailability; Thus, They Are Bioequivalent. ―Equivalent‖ Is Incorrect Because The Term
―Bioavailability‖ Is Used To Express The Extent Of Drug Absorption. ―Synergistic‖ Is
Incorrect Because This Term Refers To Two Drugs Given Together Whose Resulting Effect Is Greater
Than The Sum Of The Effects Of Each Drug Given Alone. ―Compatible‖ Is Incorrect Because This Term
Is A General Term Used To Indicate That Two Substances Do Not Have A Chemical Reaction When
Mixed (Or Given, In The Case Of Drugs) Together.
DIF: Cognitive Level: Comprehension
REF: P. 26
2. A Patient Is Receiving Medication Via Intravenous Injection. Which Information Should The NURSE
Provide For Patient Education?
A. The Medication Will Cause Fewer Adverse Effects When Given Intravenously.
B. The Medication Will Be Absorbed Slowly Into The Tissues Over Time.
C. The Medication‘S Action Will Begin Faster When Given Intravenously.
D. Most Of The Drug Is Inactivated By The Liver Before It Reaches The Target Area.
, CORRECT ANSWER: C
Intravenous Injections Are The Fastest Route Of Absorption. The Intravenous Route Does Not Affect
The Number Of Adverse Effects, The Intravenous Route Is Not A Slow Route Of Absorption, And The
Intravenous Route Does Not Cause Inactivation Of The Drug By The Liver Before It Reaches The Target
Area.
DIF: Cognitive Level: Comprehension
REF: P. 32
3. Which Is True Regarding Parenteral Drugs?
A. They Bypass The First-Pass Effect.
B. They Decrease Blood Flow To The Stomach.
C. They Are Altered By The Presence Of Food In The Stomach.
D. They Exert Their Effects While Circulating In The Bloodstream.
CORRECT ANSWER: A
Drugs Given By The Parenteral Route Bypass The First-Pass Effect, But They Still Must Be Absorbed
Into Cells And Tissues Before They Can Exert Their Effects. Enteral Drugs (Drugs Taken Orally), Not
Parenteral Drugs, Decrease Blood Flow To The Stomach And Are Altered By The Presence Of Food In
The Stomach. Parenteral Drugs Must Be Absorbed Into Cells And Tissues From The Circulation Before
They Can Exert Their Effects; They Do Not Exert Their Effects While Circulating In The Bloodstream.
DIF: Cognitive Level: Analysis
REF: P. 32
4. A Drug‘S Half-Life Is Best Defined As
A. The Time It Takes For The Drug To Elicit Half Its Therapeutic Response.
B. The Time It Takes One-Half Of The Original Amount Of A Drug To Reach The Target Cells.
C. The Time It Takes One-Half Of The Original Amount Of A Drug To Be Removed From The Body.
D. The Time It Takes One-Half Of The Original Amount Of A Drug To Be Absorbed Into The
Circulation.
CORRECT ANSWER: C
A Drug‘S Half-Life Is The Time It Takes For One-Half Of The Original Amount Of A Drug To Be Removed
From The Body. It Is A Measure Of The Rate At Which Drugs Are Removed From The Body. Answers A,
B, And D Are Not Correct Definitions Of A Drug‘S Half-Life.
PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 3RD EDITION
BY LINDA LANE LILLEY CHAPTER 1-58
,Table of Contents
Chapter 01: Nursing Practice In Canada And Drug Therapy ....................................................................... 4
Chapter 02: Pharmacological Principles ...................................................................................................... 9
Chapter 03: Legal And Ethical Considerations ........................................................................................... 14
Chapter 04: Patient Focused Considerations ............................................................................................ 19
Chapter 05: Gene Therapy And Pharmacogenomics ................................................................................ 27
Chapter 06: Medication Errors: Preventing And Responding ................................................................... 29
Chapter 07: Patient Education And Drug Therapy .................................................................................... 32
Chapter 08: Over-The-Counter Drugs And Natural Health Products ........................................................ 36
Chapter 09: Vitamins And Minerals ........................................................................................................... 40
Chapter 10: Principles Of Drug Administration ......................................................................................... 44
Chapter 11: Analgesic Drugs ...................................................................................................................... 53
Chapter 12: General And Local Anaesthetics ............................................................................................ 59
Chapter 13: Central Nervous System Depressants And Muscle Relaxants .............................................. 64
Chapter 14: Central Nervous System Stimulants And Related Drugs ...................................................... 70
Chapter 15: Antiepileptic Drugs ................................................................................................................. 75
Chapter 16: Antiparkinsonian Drugs ......................................................................................................... 80
Chapter 17: Psychotherapeutic Drugs ....................................................................................................... 84
Chapter 18: Substance Misuse ................................................................................................................... 90
Chapter 19: Adrenergic Drugs .................................................................................................................... 96
Chapter 20: Adrenergic-Blocking Drugs................................................................................................... 101
Chapter 21: Cholinergic Drugs ................................................................................................................. 106
Chapter 22: Cholinergic-Blocking Drugs .................................................................................................. 111
Chapter 23: Antihypertensive Drugs ....................................................................................................... 116
Chapter 24: Antianginal Drugs ................................................................................................................. 121
Chapter 25: Heart Failure Drugs .............................................................................................................. 126
Chapter 26: Antidysrhythmic Drugs ........................................................................................................ 132
Chapter 28: Antilipemic Drugs ................................................................................................................. 142
Chapter 29: Diuretic Drugs ....................................................................................................................... 148
Chapter 30: Fluids And Electrolytes ......................................................................................................... 154
Chapter 31: Pituitary Drugs ...................................................................................................................... 159
Chapter 32: Thyroid And Antithyroid Drugs ............................................................................................ 163
Chapter 33: Antidiabetic Drugs ................................................................................................................ 168
,Chapter 34: Adrenal Drugs ....................................................................................................................... 174
Chapter 35: Women’s Health Drugs ........................................................................................................ 178
Chapter 36: Men’s Health Drugs .............................................................................................................. 185
Chapter 37: Antihistamines, Decongestants, Antitussives, And Expectorants ...................................... 190
Chapter 38: Respiratory Drugs ................................................................................................................. 195
Chapter 39: Acid-Controlling Drugs ......................................................................................................... 200
Chapter 40: Antidiarrheal Drugs And Laxatives ...................................................................................... 206
Chapter 41: Antiemetic And Anti-Nausea Drugs ..................................................................................... 211
Chapter 42: Nutritional Supplements ...................................................................................................... 215
Chapter 43: Antibiotics, Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, And
Tetracyclines ............................................................................................................................................. 219
Chapter 44: Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, And Other Drugs ....................... 224
Chapter 45: Antiviral Drugs ...................................................................................................................... 228
Chapter 46: Antitubercular Drugs ............................................................................................................ 233
Chapter 47: Antifungal Drugs................................................................................................................... 238
Chapter 48: Antimalarial, Antiprotozoal, And Anthelmintic Drugs ........................................................ 243
Chapter 49: Anti-Inflammatory And Antigout Drugs .............................................................................. 247
Chapter 50: Immunosuppressant Drugs .................................................................................................. 252
Chapter 51: Immunizing Drugs And Pandemic Preparedness ................................................................ 256
Chapter 52: Antineoplastic Drugs Part 1: Cancer Overview And Cell Cycle–Specific Drugs .................. 261
Chapter 53: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific And Miscellaneous Drugs ................ 266
Chapter 54: Biological Response–Modifying Drugs ................................................................................ 268
Chapter 55: Anemia Drugs ....................................................................................................................... 272
Chapter 56: Dermatological Drugs........................................................................................................... 277
Chapter 57: Ophthalmic Drugs................................................................................................................. 282
Chapter 58: Otic Drugs ............................................................................................................................. 286
,Chapter 01: Nursing Practice In Canada And Drug Therapy
Lilley: Pharmacology For Canadian Health Care Practice, 3rd Canadian Edition
MULTIPLE CHOICE
1.Which Is A Judgement About A Particular Patient‘S Potential Need Or Problem?
A. A Goal
B. An Assessment
C. Subjective Data
D. A Nursing Diagnosis
CORRECT ANSWER: D
Nursing Diagnosis Is The Phase Of The Nursing Process During Which A Clinical Judgement Is Made
About How A Patient Responds To Heath Conditions And Life Processes Or Vulnerability For That
Response.
DIF:Cognitive Level: Knowledge
REF: P. 11
2. The Patient Is To Receive Oral Furosemide (Lasix) Every Day; However, Because The Patient Is Unable
To Swallow, He Cannot Take Medication Orally, As Ordered. The NURSE Needs To Contact The Physician.
What Type Of Problem Is This?
A. A ―Right Time‖ Problem
B. A ―Right Dose‖ Problem
C. A ―Right Route‖ Problem
D. A ―Right Medication‖ Problem
CORRECT ANSWER: C
This Is A ―Right Route‖ Problem: The NURSE Cannot Assume The Route And Must Clarify The Route
With The Prescriber. This Is Not A ―Right Time‖ Problem Because The Ordered Frequency Has Not
Changed. This Is Not A ―Right Dose‖ Problem Because The Dose Is Not Related To An Inability To
Swallow. This Is Not A ―Right Medication‖ Problem Because The Medication Ordered Will Not
Change, Just The Route.
DIF: Cognitive Level: Application
,REF: P. 14
3. The NURSE Has Been Monitoring The Patient‘S Progress On His New Drug Regimen Since The First
Dose And Has Been Documenting Signs Of Possible Adverse Effects. What Nursing Process Phase Is The
NURSE Practising?
A. Planning
B. Evaluation
C. Implementation
D. Nursing Diagnosis
CORRECT ANSWER: B
Monitoring The Patient‘S Progress Is Part Of The Evaluation Phase. Planning, Implementation, And
Nursing Diagnosis Are Not Illustrated By This Example.
DIF: Cognitive Level: Application
REF: P. 19
4. The NURSE Is Caring For A Patient Who Has Been Newly Diagnosed With Type 1 Diabetes Mellitus.
Which Statement Best Illustrates An Outcome Criterion For This Patient?
A. The Patient Will Follow Instructions.
B. The Patient Will Not Experience Complications.
C. The Patient Adheres To The New Insulin Treatment Regimen.
D. The Patient Demonstrates Safe Insulin Self-Administration Technique.
CORRECT ANSWER: D
Having The Patient Demonstrate Safe Insulin Self-Administration Technique Is A Specific And
Measurable Outcome Criterion. Following Instructions And Avoiding Complications Are Not Specific
Criteria. Adherence To The New Insulin Treatment Regimen Is Not Objective And Would Be Difficult To
Measure.
DIF: Cognitive Level: Application
REF: P. 13
5. Which Activity Best Reflects The Implementation Phase Of The Nursing Process For The Patient Who Is
Newly Diagnosed With Type 1 Diabetes Mellitus?
A. Providing Education Regarding Self-Injection Technique
,B. Setting Goals And Outcome Criteria With The Patient‘S Input
C. Recording A History Of Over-The-Counter Medications Used At Home
D. Formulating Nursing Diagnoses Regarding Knowledge Deficits Related To The New Treatment
Regimen
CORRECT ANSWER: A
Education Is An Intervention That Occurs During The Implementation Phase. Setting Goals And
Outcome Criteria Reflects The Planning Phase. Recording A Drug History Reflects The Assessment
Phase. Formulating Nursing Diagnoses Regarding A Knowledge Deficit Reflects Analysis Of Data
As Part Of The Planning Phase.
DIF: Cognitive Level: Analysis
REF: P. 8 | P. 13
6. The NURSE Is Working During A Very Busy Night Shift, And The Health Care Provider Has Just Given
The NURSE A Medication Order Over The Telephone, But The NURSE Does Not Recall The Route. What Is
The Best Way For The NURSE To Avoid Medication Errors?
A. Recopy The Order Neatly On The Order Sheet, With The Most Common Route Indicated
B. Consult With The Pharmacist For Clarification About The Most Common Route
C. Call The Health Care Provider To Clarify The Route Of Administration
D. Withhold The Drug Until The Health Care Provider Visits The Patient
CORRECT ANSWER: C
If A Medication Order Does Not Include The Route, The NURSE Must Ask The Health Care Provider To
Clarify It. Never Assume The Route Of Administration.
DIF: Cognitive Level: Application | Cognitive Level: Analysis
REF: P. 17
7. Which Constitutes The Traditional Five Rights Of Medication Administration?
A. Right Drug, Right Route, Right Dose, Right Time, And Right Patient
B. Right Drug, The Right Effect, The Right Route, The Right Time, And The Right Patient
C. Right Patient, Right Strength, Right Diagnosis, Right Drug, And Right Route
D. Right Patient, Right Diagnosis, Right Drug, Right Route, And Right Time
CORRECT ANSWER: A
,The Traditional Five Rights Of Medication Administration Were Considered To Be Right Drug, Right
Route, Right Dose, Right Time, And Right Patient. Right Effect, Right Strength, And Right Diagnosis Are
Not Part Of The Traditional Five Rights.
DIF: Cognitive Level: Comprehension
REF: P. 13
8. What Correctly Describes The Nursing Process?
A. Diagnosing, Planning, Assessing, Implementing, And Finally Evaluating
B. Assessing, Then Diagnosing, Implementing, And Ending With Evaluating
C. A Linear Direction That Begins With Assessing And Continues Through Diagnosing, Planning, And
Finally Implementing
D. An Ongoing Process That Begins With Assessing And Continues With Diagnosing, Planning,
Implementing, And Evaluating
CORRECT ANSWER: D
The Nursing Process Is An Ongoing, Flexible, Adaptable, And Adjustable Five-Step Process That Begins
With Assessing And Continues Through Diagnosing, Planning, Implementing, And Finally Evaluating,
Which May Then Lead Back To Any Of The Other Phases.
DIF: Cognitive Level: Application
REF: P. 8
9. When The NURSE Is Considering The Timing Of A Drug Dose, Which Is Most Important To Assess?
A. The Patient‘S Identification
B. The Patient‘S Weight
C. The Patient‘S Last Meal
D. Any Drug Or Food Allergies
CORRECT ANSWER: C
The Pharmacokinetic And Pharmacodynamic Properties Of The Drug Need To Be Assessed With
Regard To Any Drug–Food Interactions Or Compatibility Issues. The Patient‘S Identification, Weight,
And Drug Or Food Allergies Are Not Affected By The Drug‘S Timing.
,DIF: Cognitive Level: Application
REF: P. 17
10. The NURSE Is Writing Nursing Diagnoses For A Plan Of Care. Which Reflects The Correct Format For
Her Nursing Diagnosis?
A. Anxiety
B. Anxiety Related To New Drug Therapy
C. Anxiety Related To Anxious Feelings About Drug Therapy, As Evidenced By Statements Such As
―I‘M Upset About Having To Give Myself Shots‖
D. Anxiety Related To New Drug Therapy, As Evidenced By Statements Such As ―I‘M Upset About
Having To Give Myself Shots‖
CORRECT ANSWER: D
Formulation Of Nursing Diagnoses Is Usually A Three-Step Process. The Only Complete Answer Is
―Anxiety Related To New Drug Therapy, As Evidenced By Statements Such As ‗I‘M Upset About
Having To Give Myself Shots.‘‖ The Answer ―Anxiety‖ Is Missing The ―Related To‖ And ―As
Evidenced By‖ Portions. The Answer ―Anxiety Related To New Drug Therapy‖ Is Missing The ―As
Evidenced By‖ Portion Of Defining Characteristics. The ―Related To‖ Section In ―Anxiety Related To
Anxious Feelings About Drug Therapy, As Evidenced By Statements Such As ‗I‘M Upset About Having
To Give Myself Shots‘‖ Is Simply A Restatement Of The Problem ―Anxiety,‖ Not A Separate Factor
Related To The Response.
DIF: Cognitive Level: Analysis
REF: P. 9
OTHER
1. Place The Phases Of The Nursing Process In The Correct Order, Starting With The First Phase.
A. Planning
B. Evaluation
C. Assessment
D. Implementation
E. Diagnosing
CORRECT ANSWER>>
,C, E, A, D, B
DIF: Cognitive Level: Analysis
REF: P. 9
Chapter 02: Pharmacological Principles
Lilley: Pharmacology For Canadian Health Care Practice, 3rd Canadian Edition
MULTIPLE CHOICE
1. A Patient Is Receiving Two Different Drugs, Which, At Their Current Dose Forms And Dosages, Are
Both Absorbed Into The Circulation In Identical Amounts. Which Term Best Denotes That The Drugs
Have The Same Absorption Rates?
A. Equivalent
B. Synergistic
C. Compatible
D. Bioequivalent
CORRECT ANSWER: D
Two Drugs Absorbed Into The Circulation At The Same Amount (In Specific Dosage Forms) Have The
Same Bioavailability; Thus, They Are Bioequivalent. ―Equivalent‖ Is Incorrect Because The Term
―Bioavailability‖ Is Used To Express The Extent Of Drug Absorption. ―Synergistic‖ Is
Incorrect Because This Term Refers To Two Drugs Given Together Whose Resulting Effect Is Greater
Than The Sum Of The Effects Of Each Drug Given Alone. ―Compatible‖ Is Incorrect Because This Term
Is A General Term Used To Indicate That Two Substances Do Not Have A Chemical Reaction When
Mixed (Or Given, In The Case Of Drugs) Together.
DIF: Cognitive Level: Comprehension
REF: P. 26
2. A Patient Is Receiving Medication Via Intravenous Injection. Which Information Should The NURSE
Provide For Patient Education?
A. The Medication Will Cause Fewer Adverse Effects When Given Intravenously.
B. The Medication Will Be Absorbed Slowly Into The Tissues Over Time.
C. The Medication‘S Action Will Begin Faster When Given Intravenously.
D. Most Of The Drug Is Inactivated By The Liver Before It Reaches The Target Area.
, CORRECT ANSWER: C
Intravenous Injections Are The Fastest Route Of Absorption. The Intravenous Route Does Not Affect
The Number Of Adverse Effects, The Intravenous Route Is Not A Slow Route Of Absorption, And The
Intravenous Route Does Not Cause Inactivation Of The Drug By The Liver Before It Reaches The Target
Area.
DIF: Cognitive Level: Comprehension
REF: P. 32
3. Which Is True Regarding Parenteral Drugs?
A. They Bypass The First-Pass Effect.
B. They Decrease Blood Flow To The Stomach.
C. They Are Altered By The Presence Of Food In The Stomach.
D. They Exert Their Effects While Circulating In The Bloodstream.
CORRECT ANSWER: A
Drugs Given By The Parenteral Route Bypass The First-Pass Effect, But They Still Must Be Absorbed
Into Cells And Tissues Before They Can Exert Their Effects. Enteral Drugs (Drugs Taken Orally), Not
Parenteral Drugs, Decrease Blood Flow To The Stomach And Are Altered By The Presence Of Food In
The Stomach. Parenteral Drugs Must Be Absorbed Into Cells And Tissues From The Circulation Before
They Can Exert Their Effects; They Do Not Exert Their Effects While Circulating In The Bloodstream.
DIF: Cognitive Level: Analysis
REF: P. 32
4. A Drug‘S Half-Life Is Best Defined As
A. The Time It Takes For The Drug To Elicit Half Its Therapeutic Response.
B. The Time It Takes One-Half Of The Original Amount Of A Drug To Reach The Target Cells.
C. The Time It Takes One-Half Of The Original Amount Of A Drug To Be Removed From The Body.
D. The Time It Takes One-Half Of The Original Amount Of A Drug To Be Absorbed Into The
Circulation.
CORRECT ANSWER: C
A Drug‘S Half-Life Is The Time It Takes For One-Half Of The Original Amount Of A Drug To Be Removed
From The Body. It Is A Measure Of The Rate At Which Drugs Are Removed From The Body. Answers A,
B, And D Are Not Correct Definitions Of A Drug‘S Half-Life.
